Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Jan 5, 2010 vagelos p roy Director Disposition (Non Open Market) 8,595 n/a
Apr 12, 2010 vagelos p roy Director Disposition (Non Open Market) 7,952 n/a
May 14, 2010 vagelos p roy Director Sell 20,000 26.96 - 27.19
Oct 6, 2008 vagelos p roy Director Disposition (Non Open Market) 9,270 n/a
Dec 19, 2008 vagelos p roy Director Option Execute 130,000 7.41
Jan 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,771 n/a
Apr 3, 2009 vagelos p roy Director Disposition (Non Open Market) 14,976 n/a
Jun 23, 2009 vagelos p roy Director Acquisition (Non Open Market) 50,384 n/a
Jun 23, 2009 vagelos p roy Director Disposition (Non Open Market) 50,384 n/a
Jun 13, 2008 vagelos p roy Director Disposition (Non Open Market) 115,082 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Jul 10, 2008 vagelos p roy Director Disposition (Non Open Market) 30,705 n/a
Aug 4, 2008 vagelos p roy Director Disposition (Non Open Market) 114,309 n/a
Aug 4, 2008 vagelos p roy Director Acquisition (Non Open Market) 114,309 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Nov 20, 2007 vagelos p roy Director Automatic Sell 138,737 n/a
Jan 3, 2008 vagelos p roy Director Automatic Sell 8,658 n/a
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Showing 301-320 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)